What does CUSIP 14888U101 represent in this 13F holders report?

CUSIP 14888U101 is the security identifier for CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in Q2 2022?

175 institutional investors reported CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 123,180,519
Total 13F shares: 75,651,199
Share change: +5,518,717
Total reported value: $530,307,280
Put/Call ratio: 56%
Price per share: $7.01
Number of holders: 175
Value change: +$37,811,777
Number of buys: 80
Number of sells: 89

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 14888U101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ARMISTICE CAPITAL, LLC	13F	Company	6.8%	8,372,000	$69,404,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	6%	7,442,609	$61,696,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	3.8%	4,733,604	$39,242,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	3.7%	4,617,955	$38,283,000	—	31 Mar 2022	13F
LSV ASSET MANAGEMENT	13F	Company	3%	3,703,272	$30,700,000	—	31 Mar 2022	13F
ROYCE & ASSOCIATES LP	13F	Company	1.8%	2,261,907	$18,751,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.7%	2,145,254	$17,784,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	1,753,970	$14,540,000	—	31 Mar 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.2%	1,521,709	$12,611,000	—	31 Mar 2022	13F
PRUDENTIAL FINANCIAL INC	13F	Company	1.2%	1,427,445	$11,833,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	1.1%	1,319,893	$10,942,000	—	31 Mar 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	1%	1,245,030	$10,321,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	1%	1,241,326	$10,291,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	1%	1,233,992	$10,230,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.96%	1,187,119	$9,841,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.94%	1,163,809	$9,648,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.9%	1,103,361	$9,147,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.88%	1,078,251	$8,938,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.87%	1,075,282	$8,914,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.85%	1,041,967	$8,638,000	—	31 Mar 2022	13F
Allianz Asset Management GmbH	13F	Company	0.74%	915,525	$7,590,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.67%	831,365	$6,893,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.57%	698,181	$5,480,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	0.53%	656,372	$5,442,000	—	31 Mar 2022	13F
Hillsdale Investment Management Inc.	13F	Company	0.53%	649,900	$5,388,000	—	31 Mar 2022	13F
Quantedge Capital Pte Ltd	13F	Company	0.48%	597,300	$4,952,000	—	31 Mar 2022	13F
FRIESS ASSOCIATES LLC	13F	Company	0.46%	571,940	$4,741,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.46%	569,542	$4,722,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.38%	473,497	$3,925,000	—	31 Mar 2022	13F
GABLES CAPITAL MANAGEMENT INC.	13F	Company	0.36%	438,764	$3,637,000	—	31 Mar 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.34%	413,552	$3,428,000	—	31 Mar 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.33%	403,615	$3,344,000	—	31 Mar 2022	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.31%	380,206	$3,044,000	—	31 Mar 2022	13F
Informed Momentum Co LLC	13F	Company	0.3%	365,415	$3,029,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.29%	354,024	$2,935,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.29%	353,112	$2,927,000	—	31 Mar 2022	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.28%	345,348	$2,863,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.28%	341,584	$2,832,000	—	31 Mar 2022	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.26%	315,151	$2,613,000	—	31 Mar 2022	13F
UBS Group AG	13F	Company	0.26%	314,515	$2,607,000	—	31 Mar 2022	13F
GLOBEFLEX CAPITAL L P	13F	Company	0.25%	304,515	$2,524,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.24%	299,595	$2,484,000	—	31 Mar 2022	13F
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM	13F	Company	0.24%	295,899	$2,453,000	—	31 Mar 2022	13F
SEI INVESTMENTS CO	13F	Company	0.24%	295,714	$2,445,000	—	31 Mar 2022	13F
Global IMC LLC	13F	Company	0.24%	292,765	$2,427,000	—	31 Mar 2022	13F
Alberta Investment Management Corp	13F	Company	0.22%	268,012	$2,222,000	—	31 Mar 2022	13F
Fisher Asset Management, LLC	13F	Company	0.21%	260,468	$2,159,000	—	31 Mar 2022	13F
Prairiewood Capital, LLC	13F	Company	0.21%	258,073	$2,139,000	—	31 Mar 2022	13F
Man Group plc	13F	Company	0.21%	256,100	$2,123,000	—	31 Mar 2022	13F
Brandywine Global Investment Management, LLC	13F	Company	0.21%	254,667	$2,111,000	—	31 Mar 2022	13F

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q2 2022

As of 30 Jun 2022, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 175 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 75,651,199 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, BlackRock Inc., STATE STREET CORP, VANGUARD GROUP INC, LSV ASSET MANAGEMENT, MILLENNIUM MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, ROYCE & ASSOCIATES LP, GOLDMAN SACHS GROUP INC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 176 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

181

Q2 2022 holders

175

Holder diff

-6

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.